Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Towards gene therapy for the central nervous system

M J During1, L M Ashenden

  • 1University of Auckland, New Zealand.

Molecular Medicine Today
|December 19, 1998
PubMed
Summary

Gene therapy shows promise for treating genetic diseases and is now being explored for central nervous system disorders. This review highlights in vivo gene therapy applications for neurological conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene-directed enzyme prodrug therapy for localized chemotherapeutics in allograft and xenograft tumor models.

Cancer gene therapy·2014
Same author

Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy.

Gene therapy·2014
Same author

Neuropeptide y attenuates stress-induced bone loss through suppression of noradrenaline circuits.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2014
Same author

Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus.

Gene therapy·2010
Same author

Activity-dependent secretion of neuronal activity regulated pentraxin from vasopressin neurons into the systemic circulation.

Neuroscience·2007
Same author

Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behavior.

Gene therapy·2004

Area of Science:

  • Neuroscience
  • Genetics
  • Medical research

Background:

  • Gene therapy has gained significant interest, with over 2000 patients participating in global clinical trials for various genetic and acquired diseases.
  • Conventional treatments often fail for neurological disorders due to the central nervous system's unique properties.

Purpose of the Study:

  • To review the potential applications of in vivo gene therapy for neurological disorders.
  • To identify neurological conditions with the highest potential for successful genetic treatment.

Main Methods:

  • Review of existing literature on gene therapy and its application to the central nervous system.
  • Analysis of clinical trial data and research findings related to in vivo gene therapy for neurological diseases.

Main Results:

  • The central nervous system presents a promising new frontier for gene therapy.
  • In vivo gene therapy offers potential solutions for previously intractable neurological disorders.

Conclusions:

  • In vivo gene therapy holds significant potential for treating a range of neurological disorders.
  • Further research and clinical trials are warranted to fully realize the benefits of gene therapy for brain and nervous system conditions.

Related Experiment Videos